The study, “Structural Proteomics: An Opportunity Overview for Investors,” by John Sullivan, is now available through Multex at http://www.multexusa.com/products.asp, for $300. The study provides an overview of the field of structural proteomics, including recent technology developments and an analysis of company valuations. Sullivan is a drug discovery analyst at Stephens.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.